Venture Leaders Medtech Roadshow 2025: Swiss Medtech startups shine in Boston

07.10.2025 18:00, Rita Longobardi

The Venture Leaders — the Swiss National Startup Team members — have a clear objective: They envision themselves as global players and aim for international expansion. The Venture Leaders Medtech roadshow 2025 brought 10 handpicked Swiss entrepreneurs to Boston, one of the world’s largest life science hubs. The Swiss National Startup Team members benefited from market exposure, pitch sessions with investors and experts, and hands-on business development. The roadshow is organized by Venturelab and supported by EPFL, ETH Zürich, Hansjörg Wyss, Helbling Technik, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, and Vischer.

Venturelab has been organizing international investor and business development roadshows for the Swiss National Startup Teams since 2006. Ambitious entrepreneurs and their promising startups are introduced to high-caliber investors and potential customers in leading technology hubs such as Silicon Valley, Boston, Asia, Barcelona, Munich, and London.

The Venture Leaders Medtech roadshow offers a one-week deep dive into the Boston healthcare ecosystem, pitching to US investors, expert workshops, industry and market insights, and peer-to-peer exchanges with entrepreneurs. One of the world’s largest life science hubs, home to leading US medical centers and universities, including the globally renowned Harvard and MIT. Venture Leaders Medtech alumni include high-performing startups such Credentis (acquired by vVardi, KB Medical (acquired by Globus Medical), Lunaphore Technologies (acquired by Bio-Techne), STIMIT (acquired by Dräger), Abionic, Aleva Neurotherapeutics, Volumina Medical, Cutiss, Distalmotion,  MindMaze, Virtamed, ZuriMed Technologies, and many more.



Swiss medtech startups impress Boston investors and healthcare experts 
The 10 members of the Swiss National Startup Team, selected from 75 applications, not only build a strong network in the United States but are also part of a team of entrepreneurs who share the same objectives and challenges. The startups presented an exceptional lineup addressing global healthcare challenges across diverse areas, including cardiac monitoring, neonatal nutrition, neurosurgery, epilepsy detection, gastrointestinal care, home health monitoring, orthodontics, bone reinforcement, smart medical devices, and AI-assisted imaging.

"Participating in the Venture Leaders Medtech program with Venturelab was an intense and enriching experience. The program offered valuable insights into the U.S. market, reshaped my understanding of fundraising dynamics, and helped refine our expectations in today’s investment climate," highlighted Nour Ghalia Abassi Co-Founder and CEO of DigeHealth. "It also deepened my knowledge of regulatory and reimbursement systems. Alongside the input from external experts, we grew together as a team — exchanging with other founders, sharing lessons, and learning from each other’s experiences to approach challenges differently. Many thanks to VentureLab for organizing such a well-structured program — I would highly recommend it to any startup aiming to accelerate its learning and prepare for US market entry."

The week-long roadshow in Boston featured investor pitch and feedback sessions facilitated by Arnold & Porter with investors such as MedScience Ventures, Johnson & Johnson Innovation, RA Capital, Graybella Capital, Glassel Ventures, Crane Venture Partners, and Assabys Partners.

"The Venture Leaders Medtech program was both insightful and energizing. I learned from Swiss companies about their US expansion, gained valuable leads for financing and collaborations, and above all shared one intense week of camaraderie with fellow entrepreneurs who truly understand the journey," points out Eric Ménétré, CEO and Co-Founder dEEGtal.



Furthermore, the selected founders expanded their business expertise in regulatory, IP, and legal aspects of setting up US-based operations, scaling their teams, and strengthening business development and US market strategies through expert workshop sessions with Kellerhals Carrard, Vischer, and Arnold & Porter. The program included business development sessions with the Mayo Clinic (ranked as the number 1 hospital in the US), Helbling Technik, and dedicated sessions with entrepreneurs from Biognosys and Portal Instruments. The Venture Leaders Medtech also participated in the MEDevice conference, which provided opportunities for business development and networking through an international startup pitch competition featuring US, Korean, and Swiss startups.

"The Venture Leaders trip was an unparalleled opportunity for us to network with key players in the US MedTech Industry. As a relatively young startup, the program provided a great step in establishing initial US traction and I would highly recommend it to any Swiss startup," emphasizes Emily Thompson, Co-Founder and CEO of Augury Medical.



The Swiss National Medtech Team was also invited to a business reception hosted by Swiss Consul Philippe Roesle and Swissnex in Boston, where they had the opportunity to network with local business contacts.

Stefan Tuchschmied, team captain 2025, summarized the roadshow: “Yes, you’ll get tons of input on medtech, meet investors, bring your pitch to the next level, and learn to network like a pro. But the single biggest value? After this week, you’ll be friends with 10 of the most talented and extraordinary Swiss medtech startup entrepreneurs!”



Venture Leaders Medtech is organized by Venturelab and supported by EPFL, ETH Zürich, Hansjörg Wyss, Helbling Technik, Health Innovation Hub Aargau, Kellerhals Carrard, Canton de Vaud, and Vischer.

The Venture Leaders Medtech 2025 that traveled to Boston: